Animal models of silicosis: fishing for new therapeutic targets and treatments

Eur Respir Rev. 2023 Aug 9;32(169):230078. doi: 10.1183/16000617.0078-2023. Print 2023 Sep 30.

Abstract

Silicosis as an occupational lung disease has been present in our lives for centuries. Research studies have already developed and implemented many animal models to study the pathogenesis and molecular basis of the disease and enabled the search for treatments. As all experimental animal models used to date have their advantages and disadvantages, there is a continuous search for a better model, which will not only accelerate basic research, but also contribute to clinical aspects and drug development. We review here, for the first time, the main animal models developed to date to study silicosis and the unique advantages of the zebrafish model that make it an optimal complement to other models. Among the main advantages of zebrafish for modelling human diseases are its ease of husbandry, low maintenance cost, external fertilisation and development, its transparency from early life, and its amenability to chemical and genetic screening. We discuss the use of zebrafish as a model of silicosis, its similarities to other animal models and the characteristics of patients at molecular and clinical levels, and show the current state of the art of inflammatory and fibrotic zebrafish models that could be used in silicosis research.

Publication types

  • Review

MeSH terms

  • Animals
  • Disease Models, Animal
  • Humans
  • Silicon Dioxide
  • Silicosis* / drug therapy
  • Silicosis* / genetics
  • Silicosis* / pathology
  • Zebrafish* / genetics

Substances

  • Silicon Dioxide